協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/03/31 | 2,178 | 2,192.5 | 2,150.5 | 2,173 | -31.5 | -1.4% | 1,454,700 |
2025/03/28 | 2,212 | 2,212 | 2,190 | 2,204.5 | +0.5 | ±0% | 824,600 |
2025/03/27 | 2,194.5 | 2,204 | 2,180 | 2,204 | +33.5 | +1.5% | 1,242,200 |
2025/03/26 | 2,167.5 | 2,186.5 | 2,162 | 2,170.5 | -5 | -0.2% | 1,003,400 |
2025/03/25 | 2,150 | 2,181.5 | 2,148 | 2,175.5 | +25.5 | +1.2% | 709,700 |
2025/03/24 | 2,150 | 2,168.5 | 2,138 | 2,150 | +11.5 | +0.5% | 655,400 |
2025/03/21 | 2,158.5 | 2,161 | 2,136 | 2,138.5 | -39 | -1.8% | 1,898,200 |
2025/03/19 | 2,169 | 2,187.5 | 2,167 | 2,177.5 | -6.5 | -0.3% | 859,900 |
2025/03/18 | 2,182 | 2,190 | 2,166.5 | 2,184 | +5 | +0.2% | 959,900 |
2025/03/17 | 2,161.5 | 2,197.5 | 2,155.5 | 2,179 | +1 | ±0% | 622,600 |
2025/03/14 | 2,153.5 | 2,183 | 2,130 | 2,178 | -1 | ±0% | 1,844,300 |
2025/03/13 | 2,189 | 2,201 | 2,159 | 2,179 | -22 | -1% | 2,044,900 |
2025/03/12 | 2,202 | 2,221.5 | 2,183 | 2,201 | -22.5 | -1% | 1,788,700 |
2025/03/11 | 2,243.5 | 2,261.5 | 2,213.5 | 2,223.5 | -24.5 | -1.1% | 1,523,300 |
2025/03/10 | 2,250 | 2,288 | 2,233.5 | 2,248 | +25.5 | +1.1% | 1,967,900 |
2025/03/07 | 2,188 | 2,234 | 2,179.5 | 2,222.5 | +56 | +2.6% | 1,662,200 |
2025/03/06 | 2,160 | 2,169 | 2,143 | 2,166.5 | -12.5 | -0.6% | 1,255,200 |
2025/03/05 | 2,175.5 | 2,213 | 2,169.5 | 2,179 | +10 | +0.5% | 1,299,000 |
2025/03/04 | 2,160 | 2,177.5 | 2,144 | 2,169 | +18.5 | +0.9% | 1,190,700 |
2025/03/03 | 2,154 | 2,165 | 2,129 | 2,150.5 | +31 | +1.5% | 888,800 |
2025/02/28 | 2,125 | 2,148.5 | 2,108.5 | 2,119.5 | -17.5 | -0.8% | 1,794,100 |
2025/02/27 | 2,122.5 | 2,148.5 | 2,117 | 2,137 | +29 | +1.4% | 1,205,000 |
2025/02/26 | 2,110 | 2,118.5 | 2,093 | 2,108 | +19.5 | +0.9% | 1,337,100 |
2025/02/25 | 2,055 | 2,090 | 2,046 | 2,088.5 | +24.5 | +1.2% | 1,501,300 |
2025/02/21 | 2,062.5 | 2,083.5 | 2,055.5 | 2,064 | +26.5 | +1.3% | 1,358,200 |
2025/02/20 | 2,049 | 2,051.5 | 2,025 | 2,037.5 | +1 | ±0% | 965,100 |
2025/02/19 | 2,034 | 2,049.5 | 2,031 | 2,036.5 | -21 | -1% | 990,200 |
2025/02/18 | 2,045 | 2,074.5 | 2,038.5 | 2,057.5 | +4 | +0.2% | 863,300 |
2025/02/17 | 2,051 | 2,079.5 | 2,048 | 2,053.5 | -12.5 | -0.6% | 723,900 |
2025/02/14 | 2,093 | 2,105 | 2,056.5 | 2,066 | -40.5 | -1.9% | 1,335,400 |
2025/02/13 | 2,093 | 2,133 | 2,090 | 2,106.5 | +36.5 | +1.8% | 1,305,100 |
2025/02/12 | 2,076 | 2,080 | 2,045 | 2,070 | -8.5 | -0.4% | 1,706,400 |
2025/02/10 | 2,098.5 | 2,110 | 2,062.5 | 2,078.5 | -38.5 | -1.8% | 2,093,500 |
2025/02/07 | 2,135 | 2,142.5 | 2,090 | 2,117 | -123 | -5.5% | 2,813,000 |
2025/02/06 | 2,269.5 | 2,277.5 | 2,223 | 2,240 | -14 | -0.6% | 908,800 |
2025/02/05 | 2,257.5 | 2,257.5 | 2,226.5 | 2,254 | +13.5 | +0.6% | 843,500 |
2025/02/04 | 2,277 | 2,281 | 2,230.5 | 2,240.5 | +11 | +0.5% | 692,400 |
2025/02/03 | 2,280 | 2,281.5 | 2,224 | 2,229.5 | -90.5 | -3.9% | 1,229,800 |
2025/01/31 | 2,335 | 2,336.5 | 2,300 | 2,320 | -26.5 | -1.1% | 1,019,200 |
2025/01/30 | 2,328 | 2,354.5 | 2,318 | 2,346.5 | +18.5 | +0.8% | 646,800 |
2025/01/29 | 2,328.5 | 2,335.5 | 2,316 | 2,328 | -0.5 | ±0% | 540,600 |
2025/01/28 | 2,335 | 2,339.5 | 2,315.5 | 2,328.5 | +4.5 | +0.2% | 666,100 |
2025/01/27 | 2,343.5 | 2,353 | 2,319 | 2,324 | +10 | +0.4% | 633,300 |
2025/01/24 | 2,313 | 2,337.5 | 2,309.5 | 2,314 | +22 | +1% | 646,800 |
2025/01/23 | 2,274 | 2,295 | 2,257.5 | 2,292 | +4.5 | +0.2% | 696,400 |
2025/01/22 | 2,280 | 2,296.5 | 2,275.5 | 2,287.5 | +3.5 | +0.2% | 569,300 |
2025/01/21 | 2,299 | 2,301.5 | 2,275.5 | 2,284 | -10 | -0.4% | 345,800 |
2025/01/20 | 2,285 | 2,297 | 2,282 | 2,294 | +9 | +0.4% | 322,900 |
2025/01/17 | 2,283 | 2,295.5 | 2,275 | 2,285 | +2.5 | +0.1% | 656,100 |
2025/01/16 | 2,321.5 | 2,323 | 2,282.5 | 2,282.5 | -37 | -1.6% | 813,900 |
1~
50
件表示中 / 3669件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 216,900円 | -3.5% | -11.3% | 2.77% | 19.91倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 228,900円 | +5.7% | +3.9% | 2.50% | 11.38倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 415,900円 | +1.7% | -2.9% | 3.85% | 27.28倍 | 1.43倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 160,900円 | -3.5% | -50.2% | 4.97% | 13.03倍 | 0.96倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 225,400円 | +18.2% | +4.2% | 1.60% | 15.81倍 | 2.02倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム